Eterna Therapeutics (ERNA) 10-K2023 FY Annual report

Filed: 14 Mar 24, 4:36pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: abbreviated, accident, accidental, appellate, arguing, arose, asterisk, autoimmune, Bausch, Berkeley, bifurcated, bifurcation, Binder, binomial, blocker, Blvd, Brant, Brickell, Bristol, bulk, Cadent, CAR, Carlo, Celgene, Chamber, Charleston, chemist, Church, Cicala, Clarke, coincide, Colorado, Comera, Commerce, concert, confirmatory, confront, confusion, constrained, constraint, Cornerstone, cybersecurity, database, Deciphera, device, Dickinson, discord, dissuade, diversify, Dorothy, downturn, East, enduring, enterprise, Erasca, eTheRNA, Fairleigh, feature, Feb, FL, flammable, flat, foreclose, Frazier, Freebird, furlough, GE, geopolitical, grace, Hall, Houston, Huff, IAF, Ignyta, inadvertent, incorrect, incorrectly, India, instrument, Intercept, interlocutory, Johnson, judge, learned, liablity, Lomb, Luther, lymphoid, malignancy, Meyer, misuse, Monte, neurotoxicity, NIH, Oak, occupancy, Occupational, oversaw, overturn, passage, passed, pathway, PDAB, Pearl, Peter, Pfizer, Poland, postdoctoral, pressure, Pretzel, procurement, proportionate, provisional, questionnaire, quotient, ratchet, reaming, reappointed, reassessment, recapitalization, recessionary, reevaluate, repayment, repriced, repricing, repurchase, repurchased, risky, Roche, routine, Sanjeev, SC, sentiment, SEPA, Seton, settleable, shutdown, Simplification, simulation, Somvervile, spot, standalone, standby, strained, strictly, stringent, subordinated, Subtenant, SUDO, suspected, suspicion, TIA, tool, treble, tree, TX, Ukraine, unavailable, unconstitutional, underway, uneconomical, unethical, unexercised, unfair, uniformly, unlawfully, unsafe, Unstable, USFRF, vast, veterinary, Wagner, win, workplace

Removed: aggregated, Aid, allegedly, alter, BIT, collect, collection, community, consummation, content, direction, discounted, eliminate, escrow, evidencing, exemption, expectation, false, federally, Finally, forgiven, functional, inherent, innovative, lender, loading, manage, membership, merged, methodology, partner, Paycheck, penalty, PIP, PPP, preclude, prevention, pro, produce, qualifying, recover, recovered, recruit, regional, reimbursable, relief, reorganization, reserve, retention, small, soliciting, spending, split, Sponsoring, step, subscription, tangible, Treadway, treating, undertaken, unique, utilization, varied, vote

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

ERNA similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Eterna Therapeutics Inc. (the “Registrant”) on Form 10-K for the year ended December 31, 2023 (the “Report”), I, Sandra Gurrola, Senior Vice President of Finance of the Registrant, do hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) the Report, as filed with the Securities and Exchange Commission, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

Dated: March 14, 2024		/s/ Sandra Gurrola

		Sandra Gurrola Senior Vice President of Finance Eterna Therapeutics Inc.